Scholars Central

Research articlePublished 2018

Pranlukast; An Alternative Potential Leptin Stimulator: Structure-Based Virtual Screening Study

Authors: Mazin Yousif Babiker Alsafi, Deyaa EldinTaha Manalla, Islam Adil Abdulrahman, Omar Hashim Ahmed, Tarig El-Hadiyah

Immunochemistry & Immunopathology

Volume 4 · Issue 1 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Leptin is secreted by adipocytes, transported into the brain and binds to its receptor in the hypothalamus, and activates JAK-STAT3, leading to increase in “anorexigenic peptides” which normally inhibit food consumption and reduce weight.Objectives: In the current study, a hybrid approach of molecular docking and virtual screening was performed, for the identification of active alternative compounds to manage obesity disorders.Methods: Screening was performed using structure-based drug design against approved FDA drugs; molecular modeling was done using AutoDockVina; only top 10 conformers’ ligands with highest and best scores were selected. In order to increase the likelihood of successful docking, in silico Virtual Screening (VS) of selected compounds were filtered according to their molecular weight and partition coefficient; a molecular weight of less than 500 and a partitioning coefficient (log P) of less than 5 filtering is applied.Result: Here, we report the screening of four compounds that have showed maximum binding affinity against Leptin receptor, obtained through the ZINC database. A VS approach coupled with docking energies illustrated that Pranlukast could be potential stimulator compounds for targeting Leptin receptor.Conclusion: We proposed that Pranlukast may be more potent Leptin receptor stimulator analogue based on the binding energy values. Further work can be extended to study the receptor ligand interactions experimentally and evaluation of their biological activity would help in designing novel therapeutic lead for the management of obesity disorders.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Immunochemistry & Immunopathology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunochemistry & Immunopathology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Mazin Yousif Babiker Alsafi”
  • BylineArticles whose byline prints “Deyaa EldinTaha Manalla”
  • BylineArticles whose byline prints “Islam Adil Abdulrahman”
  • BylineArticles whose byline prints “Omar Hashim Ahmed”
  • BylineArticles whose byline prints “Tarig El-Hadiyah”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels